Search Results - "MIGLIORI, Giovanni B"

Refine Results
  1. 1

    The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue? by Dheda, Keertan, Prof, Migliori, Giovanni B, Prof

    Published in The Lancet (British edition) (25-02-2012)
    “…[...] treatment-related outcome data have become available in programmes using second-line drugs such as capreomycin and paraaminosalicylic acid in settings of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Multidrug- and extensively drug-resistant tuberculosis, Germany by Eker, Barbara, Ortmann, Johannes, Migliori, Giovanni B, Sotgiu, Giovanni, Muetterlein, Ralf, Centis, Rosella, Hoffmann, Harald, Kirsten, Detlef, Schaberg, Tom, Ruesch-Gerdes, Sabine, Lange, Christoph

    Published in Emerging infectious diseases (01-11-2008)
    “…We evaluated risk factors and treatment outcomes associated with multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) in Germany in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    High rate of hypothyroidism in multidrug-resistant tuberculosis patients co-infected with HIV in Mumbai, India by Andries, Aristomo, Isaakidis, Petros, Das, Mrinalini, Khan, Samsuddin, Paryani, Roma, Desai, Chitranjan, Dalal, Alpa, Mansoor, Homa, Verma, Reena, Fernandes, Dolorosa, Sotgiu, Giovanni, Migliori, Giovanni B, Saranchuk, Peter

    Published in PloS one (23-10-2013)
    “…Adverse events (AEs) among HIV-infected patients with multidrug-resistant tuberculosis (MDR-TB) receiving anti-TB and antiretroviral treatments (ART) are…”
    Get full text
    Journal Article
  8. 8

    Harnessing the energy of the corporate sector to end TB: BE health by Bettex, Anne Marie, Dias, Hannah Monica Yesudian, Migliori, Giovanni B., Raviglione, Mario C.

    “…The World Health Organization (WHO) estimates that 3 million people with TB are missing’ from the official information system. They remain often undiagnosed…”
    Get full text
    Journal Article
  9. 9

    Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence by Pontali, Emanuele, Sotgiu, Giovanni, Tiberi, Simon, D'Ambrosio, Lia, Centis, Rosella, Migliori, Giovanni B

    Published in The European respiratory journal (01-11-2017)
    “…The treatment of multidrug-resistant (MDR) or extensively drug-resistant (XDR) tuberculosis (TB) remains a challenge for clinicians for several reasons,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Multidrug-resistant tuberculosis – Authors' reply by Menzies, Dick, Benedetti, Andrea, Migliori, Giovanni B, Nahid, Payam, Seaworth, Barbara

    Published in The Lancet (British edition) (27-07-2019)
    “…[...]this situation occurred only for a few analyses—primarily for the injectables and fluoroquinolones (see table 3 in our Article,1 although this was not the…”
    Get full text
    Journal Article
  12. 12

    Time to review treatment of isoniazid-resistant tuberculosis? by D'Ambrosio, Lia, Migliori, Giovanni B, Sotgiu, Giovanni

    Published in The Lancet infectious diseases (01-02-2017)
    “…The 2014 reported global rate of isoniazid resistance not associated with rifampicin resistance was 9·5%,1 and the estimated prevalence of multidrug-resistant…”
    Get full text
    Journal Article
  13. 13

    Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients by Ahuja, Shama D, Ashkin, David, Avendano, Monika, Banerjee, Rita, Bauer, Melissa, Bayona, Jamie N, Becerra, Mercedes C, Benedetti, Andrea, Burgos, Marcos, Centis, Rosella, Chan, Eward D, Chiang, Chen-Yuan, Cox, Helen, D'Ambrosio, Lia, DeRiemer, Kathy, Dung, Nguyen Huy, Enarson, Donald, Falzon, Dennis, Flanagan, Katherine, Flood, Jennifer, Garcia-Garcia, Maria L, Gandhi, Neel, Granich, Reuben M, Hollm-Delgado, Maria G, Holtz, Timothy H, Iseman, Michael D, Jarlsberg, Leah G, Keshavjee, Salmaan, Kim, Hye-Ryoun, Koh, Won-Jung, Lancaster, Joey, Lange, Christophe, de Lange, Wiel C M, Leimane, Vaira, Leung, Chi Chiu, Li, Jiehui, Menzies, Dick, Migliori, Giovanni B, Mishustin, Sergey P, Mitnick, Carole D, Narita, Masa, O'Riordan, Philly, Pai, Madhukar, Palmero, Domingo, Park, Seung-kyu, Pasvol, Geoffrey, Peña, Jose, Pérez-Guzmán, Carlos, Quelapio, Maria I D, Ponce-de-Leon, Alfredo, Riekstina, Vija, Robert, Jerome, Royce, Sarah, Schaaf, H Simon, Seung, Kwonjune J, Shah, Lena, Shim, Tae Sun, Shin, Sonya S, Shiraishi, Yuji, Sifuentes-Osornio, José, Sotgiu, Giovanni, Strand, Matthew J, Tabarsi, Payam, Tupasi, Thelma E, van Altena, Robert, Van der Walt, Martie, Van der Werf, Tjip S, Vargas, Mario H, Viiklepp, Pirett, Westenhouse, Janice, Yew, Wing Wai, Yim, Jae-Joon

    Published in PLoS medicine (01-08-2012)
    “…Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso by Miotto, Paolo, Saleri, Nuccia, Dembelé, Mathurin, Ouedraogo, Martial, Badoum, Gisèle, Pinsi, Gabriele, Migliori, Giovanni B, Matteelli, Alberto, Cirillo, Daniela M

    Published in BMC infectious diseases (28-08-2009)
    “…Drug-resistant tuberculosis (DR-TB) is considered a real threat to the achievement of TB control. Testing of mycobacterial culture and testing of drug…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Drug-resistant tuberculosis by Pontali, Emanuele, Matteelli, Alberto, Migliori, Giovanni B

    Published in Current opinion in pulmonary medicine (01-05-2013)
    “…PURPOSE OF REVIEWThis review discusses the recent evidence on epidemiology, diagnosis, and treatment of drug-resistant and multidrug-resistant (MDR)…”
    Get full text
    Journal Article
  18. 18

    Treatment Strategy for Rifampin-Susceptible Tuberculosis by Burman, William, Fox, Greg J., Horsburgh, C. Robert, Boeree, Martin J., Heinrich, Norbert, Aarnoutse, Rob E., Leung, Chi Chiu, Migliori, Giovanni B., Paton, Nicholas I., Cousins, Christopher, Suresh, Celina

    Published in The New England journal of medicine (15-06-2023)
    “…To the Editor: With regard to the Two-Month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-Sensitive Tuberculosis (TRUNCATE-TB)…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection by Ferrara, Giovanni Ph.D, Losi, Monica, Fabbri, Leonardo M, Migliori, Giovanni B, Richeldi, Luca, Casali, Lucio

    “…Tuberculosis (TB) still represents a monumental problem, with more than two million deaths every year worldwide. The current diagnostics for TB offer…”
    Get full text
    Journal Article